{"title":"Himalayan Pink Salt as a Healthier Substitute in Lowering the Risk of Dietary Salt Induced Cognitive Insults in Experimental Rats","authors":"P. Keerthana, Subramanian Sarada","doi":"10.36959/734/384","DOIUrl":"https://doi.org/10.36959/734/384","url":null,"abstract":"Alzheimer’s disease (AD) belonging to the class of tauopathies, is a major cause of dementia globally. Observational studies in the aging population have reported that excessive dietary salt consumption is one of the risk factors that contribute to the pathological processes that underlie dementia and cognitive impairment. Regulation of the daily salt intake and consumption of alternative nutritional salts, if proven, may serve as a cost-effective and feasible approach in lowering the risk of dementia. With this background, the objective of the current study included assessment of the putative benefits of Himalayan pink salt with regard to its effects on spatial memory in comparison with that of common salt using rat as an experimental model. The results of the study showed that Himalayan pink salt, even at 5-10 fold higher concentrations of the salt over the permissible daily intake limits, could exhibit a positive effect on learning and memory in Barnes maze task and improved nitric oxide levels. Phosphorylated tau levels remained comparable to that of control group whereas common salt inflicted greater insults leading to elevated levels of pathological form of tau and compromised spatial memory. These findings suggest that Himalayan pink salt may serve as a healthier salt substitute towards lowering the risk or severity of dietary salt induced form of AD.","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48106546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. ChanAgnes, Lee TszLok, Sze Sophia, R. HamblinMichael
{"title":"Photobiomodulation Improves Memory in Mild Cognitive Impairment: Three Case Reports","authors":"S. ChanAgnes, Lee TszLok, Sze Sophia, R. HamblinMichael","doi":"10.36959/734/383","DOIUrl":"https://doi.org/10.36959/734/383","url":null,"abstract":"Three patients (mean age = 62) received 18-sessions of PBM stimulation twice per week for nine weeks. Each patient was assessed with Rey- Osterrieth Complex Figure Test (Rey-O testing visual memory) and Hong Kong List Learning Test (HKLLT testing verbal memory), Clinical Dementia Rating Scale (CDR), Functional Activities Questionnaire (FAQ), Geriatric Anxiety Scale-10 Item Version (GAS-10) and Chinese Geriatric Depression Scale (CGDS) before and after PBM.","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45906857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ameliorative Effects of Intranasal AntagomiR-125b in AD","authors":"Xia Chun, C. Neelima","doi":"10.36959/734/380","DOIUrl":"https://doi.org/10.36959/734/380","url":null,"abstract":"Alzheimer's disease (AD) is a global public health crisis. Currently, there are no treatments to prevent or halt the disease. Given the precedence of chronic neuroinflammation in triggering AD-like neurodegeneration and an observed upregulation of NFkB-driven miRs i.e. mir-125b positively correlating with AD, silencing specific micro-RNA with antisense-microRNA (antagomir) to miR-125b was undertaken to evaluate its efficacy in ameliorating AD-like neurodegeneration in 5XFAD transgenic mice modeling AD.","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45369378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Kociolek, K. Fernández, Yian Gu, Stephanie Cosentino, C. Zhu, Y. Stern
{"title":"The presence of moderate extrapyramidal signs predicts poorer outcomes in a community‐based cohort of multi‐ethnic demented elders: Developing topics","authors":"A. Kociolek, K. Fernández, Yian Gu, Stephanie Cosentino, C. Zhu, Y. Stern","doi":"10.7916/D8-ZNGM-BS85","DOIUrl":"https://doi.org/10.7916/D8-ZNGM-BS85","url":null,"abstract":"","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86518459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Monfared, Y. Stern, M. Irizarry, S. Doogan, Quanwu Zhang
{"title":"Evaluation of patient burden using online social media in mild cognitive impairment: Dementia care research (research projects; nonpharmacological) / Assessment and care planning","authors":"A. Monfared, Y. Stern, M. Irizarry, S. Doogan, Quanwu Zhang","doi":"10.7916/D8-S110-6M36","DOIUrl":"https://doi.org/10.7916/D8-S110-6M36","url":null,"abstract":"","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":"63 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76475401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Boyle, S. Scarlett, S. Knight, C. Looze, Y. Stern, I. Robertson, Kenny Rose Anne, R. Whelan
{"title":"Validation of composite proxy measures of cognitive reserve: What can longitudinal cohorts tell us about the association between modifiable dementia risk factors and the ageing","authors":"R. Boyle, S. Scarlett, S. Knight, C. Looze, Y. Stern, I. Robertson, Kenny Rose Anne, R. Whelan","doi":"10.7916/D8-T5QB-KM68","DOIUrl":"https://doi.org/10.7916/D8-T5QB-KM68","url":null,"abstract":"","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72994563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lukas Frontzkowski, N. Franzmeier, J. Neitzel, Ying Luan, C. Habeck, Y. Stern, M. Ewers
{"title":"Left frontal hub connectivity enhances task‐related brain network segregation and cognition in aging: Implications for reserve: Neuroimaging/Normal brain aging","authors":"Lukas Frontzkowski, N. Franzmeier, J. Neitzel, Ying Luan, C. Habeck, Y. Stern, M. Ewers","doi":"10.7916/D8-EA6B-PS43","DOIUrl":"https://doi.org/10.7916/D8-EA6B-PS43","url":null,"abstract":"","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75017354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Novel Concept is Needed for Combating Alzheimer's Disease and NeuroHIV.","authors":"Xiu-Ti Hu","doi":"10.36959/734/377","DOIUrl":"https://doi.org/10.36959/734/377","url":null,"abstract":"<p><p>Both Alzheimer's disease (AD) and HIV-associated neurocognitive disorders (HAND) could progress to dementia, a severe consequence of neurodegenerative diseases. Cumulating evidence suggests that the β-amyloid (Aβ) theory, currently thought to be the predominant mechanism underlying AD and AD-related dementia (ADRD), needs re-evaluation, considering all treatments and new drug trials based upon this theory have been unsuccessful. Similar intention for treating HAND, including HIV-associated dementia (HAD), has also failed. Thus, novel theory, hypothesis, and therapeutic strategies are desperately needed for future study and effective treatments of AD/ADRD and HAND. There are numerous potential upstream mechanisms that may cause AD and/or HAND; but it is unrealistic to identify all of them. However, it is realistic and feasible to intervene the downstream mechanism of these two devastating neurodegenerative diseases by blocking the final common path to neurotoxicity mediated by overactivation of NMDA receptors (NMDARs) and voltage-gated calcium channels (VGCCs). Such a combined pharmacological intervention will likely ameliorate neuronal Ca<sup>2+</sup> homeostasis by diminishing overactivated NMDAR and VGCC-mediated Ca<sup>2+</sup> dysregulation (i.e., by reducing excessive Ca<sup>2+</sup> influx and intracellular levels, [Ca<sup>2+</sup>]in)-induced hyperactivity, injury, and death of neurons in the critical brain regions that regulate neurocognition in the context of AD/ADRD or HAND, especially during aging. Here we present a novel theoretical concept, hypothesis, and working model for switching the battlefield from searching-and-fighting the original mechanism that may cause AD or HAND, to abolishing AD- and neuroHIV-induced neurotoxicity mediated by NMDAR and VGCC over activation, which may ultimately improve the therapeutic strategies for treating AD and HAND.</p>","PeriodicalId":93069,"journal":{"name":"Alzheimers disease & dementia","volume":"4 1","pages":"85-91"},"PeriodicalIF":0.0,"publicationDate":"2020-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38415523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}